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The impact of interventions 
to improve adherence to 
preventive measures on 
the incidence of nosocomial 
infections in ICUs
ABSTRACT
Half of all life-threating nosocomial infections occur in intensive care units (ICUs) and, despite the advances in intensive 
care, the incidence of nosocomial infections is still high. About one third of nosocomial infections are considered preventa-
ble. Awareness of risk factors, adherence to preventive measures and collaboration of all members participating in preventi-
ve programmes can lead to reduction of the incidence of nosocomial infections and thus can produce a positive impact on 
reducing morbidity, mortality and healthcare costs. A retrospective surveillance study was performed in a 14-bed medical 
ICU to identify device-related infections before and after the preventive interventions. Ventilator-associated pneumonia 
(VAP), central line-associated bloodstream infections (CLABSI) and catheter-associated urinary tract infections (CAUTI) 
were obtained and compared before and after the interventions.  In the year before the interventions, device-related noso-
comial infections were diagnosed in 7.9% out of 737 hospitalised patients in the ICU, and in the year after the interventions 
they were diagnosed in 5.1% out of 684 hospitalised patients. Before the interventions, the infection rates were distributed 
as follows: 7.5 CLABSI/1000 catheter days, 28.4 VAP/1000 ventilator days, 6.5 CAUTI/1000 catheterisation days. After the 
interventions, the rates were distributed as follows: 2.5 CLABSI/1000 catheter days, 26.5 VAP/1000 ventilator days and 4.1 
CAUTI/1000 catheterisation days. The implementation of effective preventive measures and maintaining strict surveillance 
is the basis of limiting the risk of nosocomial infections. Since hospital nosocomial infection rate is considered an indicator 
of quality and safety of care, all infection control activities are focused to decrease rate of nosocomial infections. 
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Introduction
Nosocomial infections are a worldwide 
health care problem and are associated 
with increased morbidity and mortality, 
prolonged duration of hospital stay and 
increased economic costs. Nosocomial 
infections affect about 5-10% of hospita-
lised patients. Patients in intensive care 
units (ICUs) have a 5-10 times higher 
risk of acquiring nosocomial infections 
than patients in other wards. (1-4) The 
European Prevalence of Infection in 
Intensive Care Study (EPIC), involving 
over 4,500 patients, demonstrated that 
the nosocomial infections prevalen-
ce rate in ICU was 20.6%. (5) So the 
majority of all nosocomial infections 
are acquired in ICUs, although ICUs 
account for about 10% of all hospital 
beds. The reason for this high incidence 
is multifactorial and includes the use of 
invasive procedures, the high prevalen-
ce of multidrug-resistant pathogens and 
specific patient characteristics like seve-
re acute physiologic derangements, 
immunocompromised status and chro-
nic comorbid illness. (6) The most com-
mon nosocomial infections in ICUs are 
bloodstream infections, pneumonia, 
urinary tract infections and surgical site 
infections. Nosocomial infections are 
associated with a mortality rate varying 
from 5% to 35%. (2,5,7) Epidemiological 
data regarding nosocomial infections in 
ICUs in Croatia are lacking. 
Nowadays nosocomial infections are 
considered an undesirable outcome 
of treatment. A significant number of 
these infections is preventable. Preven-
tion of nosocomial infections includes 
two major strategies: infection control 
measures and control of antibiotic 
use. Infection control programmes are 
the responsibility of all services and 
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individuals providing health care. The 
responsible health authority has to pro-
vide a national prevention programme, 
and both hospital administration and 
staff are obligated to work together on 
reduction of nosocomial infections. 
(8) The important factor in an infecti-
on control strategy is surveillance, a 
process of identifying the local hos-
pital problem and priorities in preven-
tion activities. Nosocomial infections 
surveillance includes collecting data 
and counting rates, and analysing and 
interpreting results. That is why good 
documentation is crucial in the process 
of surveillance. The aim of surveillance 
is finding an optimal intervention as a 
preventive action and evaluating the 
impact of these interventions. (9-11) 
Approximately one third of nosocomial 
infections are considered preventable 
and that is why they are considered an 
indicator of the quality of patient care 
and a patient safety issue.
Here we present our attempt to improve 
ICU medical staff awareness on adhe-
rence to preventive measures in order 
to improve our infection control strategy 
and reduce the incidence of nosocomi-
al infections. 
Materials and methods
In an attempt to reduce the rate of 
nosocomial infections, a strict infecti-
on control strategy was implemented 
in a 14-bed medical ICU from Janu-
ary 2012. The first step included edu-
cational interventions. ICU staff was 
informed through a lecture about noso-
comial infections, the most common 
pathogens in the hospital and antimi-
crobial resistance and ways of transmi-
ssion. This improved staff awareness 
of nosocomial infections and of the 
need for preventive interventions. The 
measures to reduce person-to-person 
transmission were implemented. All 
ICU staff underwent a hand hygiene 
education and afterwards good hand 
hygiene compliance was secured by 
continuing observation and surveillan-
ce from the Hospital Infection Control 
Commission. In accordance with the 
hospital management, materials nee-
ded for preventive precautions were 
obtained: enough gloves, gowns, ste-
rile material, antiseptics, dressings for 
central vein catheters, closed aspirati-
on systems etc. Architectural changes 
in the department were also made so 
that infected patients could be properly 
isolated. A new environmental cleaning 
strategy was implemented which also 
included periodic cleaning with hydro-
gen peroxide. At the same time, a devi-
ce-specific strategy was conducted in 
order to minimise these infections. As 
the most common nosocomial infecti-
ons in ICUs are related to invasive pro-
cedures, all medical staff was informed 
of the current guidelines related to the 
placement and management of intra-
vascular catheters and urinary bladder 
catheters, as well as the management 
of patients on mechanical ventilation. All 
invasive procedures were documented 
in electronic form in a patient medical 
history database from the moment that 
the device was placed to the moment 
that it was removed, including all data 
conducted at regular daily surveillan-
ce. From the microbiological point of 
view, a screening swab for MRSA and 
Klebsiella pneumoniae KPC were obta-
ined from all patients admitted to the 
ICU, together with other microbiologi-
cal specimens when the infection was 
present or suspected. Audits from a 
microbiologist and clinical pharmaco-
logist were made in order to be up to 
date with the hospital’s microbiological 
situation and to improve antimicrobi-
al utilisation. In collaboration with the 
Hospital Infection Control Commissi-
on, bundles to prevent device-related 
infections were implemented. First, the 
central line infection prevention bundle 
was implemented, then a urinary tract 
infection prevention bundle, and the 
last was a bundle for the prevention 
of ventilator-associated pneumonia. 
Adequate data collection was neces-
sary in order to monitor trends, identify 
needs for new interventions and identify 
areas for improvement in patient care. 
All data regarding patients hospitalised 
in the ICU (presence of devices and 
procedures with a known risk of infecti-
on, antimicrobial therapy, microbiologi-
cal laboratory results and medical and 
nursing chart review) which were previ-
ously documented in multiple sources 
were put together in a specially-desi-
gned computerised programme with 
the possibility to search and analyse 
data. The collected data were the basis 
for an evaluation of the impact of imple-
mented interventions and of the need 
for changing the strategy. 
Here, we present a retrospective study 
of nosocomial infection surveillance in a 
14-bed medical ICU. Nosocomial infec-
tions were defined according to criteria 
of the Centre for Disease Control and 
Prevention (CDC) criteria, and invasive 
Table 1. Comparison of device related nosocomial infections rates before 






Rate of CLABSI/1000 
catheter days
7.5 2.5 0.017 S
Rate of VAP/1000 
ventilator days
28.4 26.5 0.055 NS
Rate of CAUTI/1000 
catheter days
6.5 4.1 0.067 NS
CAUTI, catheter-associated urinary tract infections; CLABSI, central line-associated 
bloodstream infections; VAP, ventilator-associated pneumonia 
*result is significant at p<0,05
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device-related infections were defined 
according to the National Nosocomial 
Infection Surveillance System (NNIS) 
criteria. (2,4) An intervention to improve 
adherence to preventive measures star-
ted at January 2012. The rates of the 3 
most common nosocomial infections – 
ventilator-associated pneumonia (VAP), 
central line-associated bloodstream 
infections (CLABSI) and catheter-asso-
ciated urinary tract infections (CAUTI) 
were compared before and after the 
interventions. Data for the study were 
obtained from all admissions between 
January 2011 and January 2013. 
Results
In the year before the interventions 
the device-related nosocomial infec-
tions were diagnosed in 7.9% out of 
737 hospitalised patients in the ICU. 
The most common infection was VAP 
(55%), followed by CLABSI (26%) and 
CAUTI (19%). Rates of device-related 
nosocomial infections were distributed 
as follows: 7.5 CLABSI/1000 catheter 
days, 28.4 VAP/1000 ventilator days 
and 6.5 CAUTI/1000 catheterisation 
days. (table 1)
In the year after interventions, device-
related nosocomial infections were dia-
gnosed in 5.1% out of 684 hospitalised 
patients in ICU. As before intervention, 
VAP was the most common infection 
(52%), followed by CAUTI (36%) and 
CLABSI (12%). The rates of device-
related nosocomials infections were 
distributed as follows: 2.5 CLABSI/1000 
catheter days, 26.5 VAP/1000 ventilator 
days and 4.1 CAUTI/1000 catheterisati-
on days. (table 1)
The results show a reduction of all devi-
ce-related nosocomial infections rates 
after the intervention. The reduction of 
the CLABSI rate after the intervention 
was statistically significant, while the 
reduction of VAP and CAUTI was not 
statistically significant. (table 1)
When multidrug-resistant pathogens 
were analysed both in the year before 
and after the interventions, the three 
most frequent pathogens were Aci-
netobacter baumanii anitratus, Pseu-
domonas aeruginosa and Klebsiella 
pneumoniae ESBL. 
Discussion
Data from CDC shows that the most 
common nosocomial infections are 
CAUTI (40%), VAP (25%) and CLABSI 
(10%). (2) The EPIC study showed that 
20.6% patients had an ICU-acquired 
infection and the distribution was as 
follows: pneumonia 46.9%, lower respi-
ratory tract infection 17.8%, urinary tract 
infection 17.6%, bloodstream infecti-
on 12%. (5) The Rosenthal multicenter 
prospective cohort surveillance study 
showed that rates of device-related 
infections in ICUs are much higher in 
ICUs from the developing world com-
pared to those in the United States 
(US). The rate for CLABSI in develo-
ped countries was 7.6 per 1000 cathe-
ter days versus 2.0 per 1000 catheter 
days for a comparable ICU in the US. 
The overall rate of VAP was also much 
higher in developing countries than in 
the US, at 13.6 versus 3.3 per 1000 
ventilator days. The same trend exists 
for CAUTI: 6.3 versus 3.3 per 1000 cat-
heter days, respectively. (12) Based on 
the surveillance studies between 2008 
and 2012, CDC reported that significant 
progress had been made in the pre-
vention of nosocomial infections and a 
44% reduction in CLABSI was reported. 
The same trend exists for surgical site 
infections, while a 3% increase was 
reported for CAUTI. (2) Epidemiological 
data about nosocomial infections in 
ICU in Croatia are lacking. Majority of 
data are estimations, and one of rare 
studies about this topic is a Baršić et al. 
incidence study on nosomial infections 
in critically ill infectious disease patients 
over a 7-year period. (13)
The prevention of nosocomial infecti-
ons is fundamental and can be achi-
eved through strict infection control 
measures, educational interventions, 
good antimicrobial use and close colla-
boration of all members who provide 
health care. Approximately one third of 
nosocomial infections are considered 
preventable. Umsheid et al. described 
how 65-70% of CLABSI and CAUTI and 
55% of VAP are preventable. (3)  
In order to reduce the incidence of 
nosocomial infections in our 14-bed 
medical ICU, we conducted a series 
of interventions in order to improve the 
awareness of ICU staff about adheren-
ce to preventive measurements. The 
most important part of our strategy was 
the implementation of a new way of 
documenting all procedures and acti-
ons related to devices. Documentation 
is in electronic form and all the actions 
taken with the device, together with the 
name of the staff member who perfor-
med it, is clearly visible. By documen-
ting all procedures, the staff is obliged 
to work according to the guidelines and 
to good medical practice. Analysis of 
our data showed the highest incidence 
of VAP, while the incidence of CAUTI 
was the lowest. When compared with 
the Rosenthal study, the post- inter-
vention rates for CLABSI and CAUTI 
were similar to the rates in the US, while 
the VAP rate was much higher. After 
the interventions, the reduction of devi-
ce-related nosocomial infections rates 
was registered. The reduction of the 
CLABSI rate after the intervention was 
statistically significant, while the reduc-
tion of the CAUTI and VAP rates was not 
statistically significant. This is because, 
at the beginning of the interventions, 
emphasis was put on the reduction of 
the CLABSI rate, so the results were 
best for this device-related nosocomial 
infection. When desirable results for 
CLABSI were achieved, we placed our 
attention on the reduction of the VAP 
rate, so a VAP prevention bundle was 
implemented with a new protocol of 
care for patients on mechanical ven-
tilation. As a result of these interventi-
ons, we are expecting positive results in 
reducing the VAP rate in the future.  
Conclusion
The implementation of effective preven-
tive measures and maintaining strict 
surveillance is the basis for limiting the 
risk of nosocomial infections and can 
thus produce a positive impact on redu-
cing morbidity, mortality and healthcare 
costs. Since the hospital nosocomi-
al infection rate is considered as an 
indicator of quality and safety of care, 
all infection control activities are focu-
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